10:00 am – 10:45 am | Breakfast & Registration

10:45 am – 11:00 am | Welcome Note
Matthew Streeter, General Manager, Catalent Nottingham

Matt Ling (Moderator), Director, Scientific Services, Catalent Nottingham

11:00 am – 11:30 am |

Formulating in Early Discovery: Embedding Formulation Considerations into Hit-To-Lead Optimization

David Pearson, Director of Form and Formulation, Sygnature Discovery

11:30 am – 12:00 pm | Formulating with Less API: Application of API Sparing Techniques in Oral Drug Development

Karl Box, Chief Scientific Officer, Pion Inc

12:00 pm – 1:00 pm | Power Lunch

1:00 pm – 1:30 pm | Formulating for Success: Early-Phase Strategies to Avoid Costly Setbacks

Stephen Tindal, Director, Scientific Advisory, Europe, Catalent

1:30 pm – 2:00 pm |Manufacturing Insight: Lessons from 12 Years of the Manufacturing Classification System

Kendal Pitt, Visiting Professor, University of Strathclyde & Honorary Professor, Leicester School of Pharmacy, De Montfort University

2:00 pm – 2:30 pm | Refresh & Recharge

2:30 pm – 3:00 pm | Fast-Tracking Clinical Development: Navigating UK Clinical Trial Regulations to Reduce Risk and Accelerate Timelines

Karen Chalk, Head of Clinical Project Management & Regulatory Affairs, HMR

Sally Dowen, Director, Lealto Consulting

3:00 pm – 3:30 pm | Founder's Insight: Tackling Early Drug Development Challenges with Strategic Partners That Deliver

Emilia Neuwirt, Co-Founder, CEO EMUNO Therapeutics

3:30 pm – 4:15 pm | Panel Discussion: Securing Capital in a Competitive Market - What Early-Stage Pharma Needs to Know

Ronak Savla, Director, Strategic Ventures, Catalent

Graham Mills, Principal, Abingworth

Owen Smith, Partner, 4BIO Capital

Angelos Georgakis, Executive Coach to Biotech Leaders

Jack O’Meara, CEO of Helico

4:15 pm – 5:00 pm| Closing & Networking Cocktail

Sherief Shaaban, VP and Chief Commercial Officer, Catalent

Accelerate Small Molecule Development with Smart Formulation & Funding